Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Risperdal Consta 37.5mg powder and solvent for prolonged-release suspension for injection vials (Janssen-Cilag Ltd) |
| BNF code | 0402020AABBACAC |
| Virtual Medicinal Product | Risperidone 37.5mg powder and solvent for prolonged-release suspension for injection vials |
| Name | Risperdal Consta 37.5mg powder and solvent for prolonged-release suspension for injection vials |
| Abbreviated name | Risperdal Consta 37.5mg inj vials |
| Date of name applicability | 1 Dec 2024 |
| Previous name | Risperdal Consta 37.5mg powder and solvent for suspension for injection vials |
| Supplier | Janssen-Cilag Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intramuscular |
| Actual Medicinal Product Packs | |
| Risperdal Consta 37.5mg powder and solvent for prolonged-release suspension for injection vials (Janssen-Cilag Ltd) 1 vial | |
dm+d data retrieved from TRUD: release NHSBSA_6.4.0_20250630000001, imported on 30th June 2025 at 05:10:36.